India disagrees with WHO over HCQ assessment – WHO trial dosages four times higher than Indian trials
29/05/2020 No Comments
Source: Zeekannada New Delhi [India], May 29 (ANI): After the Union Health Ministry expressed reservations about the World Health Organisation’s (WHO) advisory to suspend hydroxychloroquine